Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations

Clinical Infectious Diseases

Volumn 35, Issue 4, 2002, Pages 370-377

  Hak, Eelko ^a,f   Nordin, James ^a   Wei, Feifei ^a   Mullooly, John ^c   Poblete, Sung ^d   Strikas, Raymond ^e   Nichol, Kristin L ^a,b  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^b VA MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d Oxford Health Plan   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HEALTH PROGRAM; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MORTALITY; OUTCOMES RESEARCH; PHYSICAL DISEASE; PNEUMONIA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNITED STATES;

AGED; COHORT STUDIES; FEMALE; HEALTH SERVICES FOR THE AGED; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MANAGED CARE PROGRAMS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037102949     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341403     Document Type: Article

References (42)

1. The impact of influenza epidemics on mortality: Introducing a severity index
2. The impact and cost of influenza in the elderly
3. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
4. Clinical effectiveness of influenza vaccination in Manitoba
5. Influenza vaccine effectiveness in preventing hospitalization for pneumonia among the elderly during influenza A and type B seasons
6. Study on the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database
7. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons in the community
8. Influenza and pneumococcal vaccination levels among persons aged 65 years - United States, 1999
9. Influenza vaccination in 29 countries: An update to 1997
10. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococal vaccinations - United States, 1996
11. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults
12. Adult immunization: Knowledge, attitudes and practices - DeKalb and Fulton counties, Georgia, 1988
13. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-81
14. Acute respiratory illness among immunized and non-immunized patients with high-risk factors during a split season of influenza A and B
15. The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial
16. Benefits of influenza vaccination for low-, intermediate- and high-risk senior citizens
17. Influenza vaccination of elderly persons: Cost-effectiveness in a health maintenance organization
18. Influenza vaccination of elderly persons: Reduction in pneumonia and influenza hospitalizations and deaths
19. Influenza immunization policies in Europe and the United States
20. Notice to readers: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season
21. Notice to readers: Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season
22. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: Data from 3 health plans
23. Confounding and indication for treatment in evaluation of drug treatment for hypertension
24. Update: Influenza activity - United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine
25. Update: Influenza activity - United States and worldwide, 1996-97 season, and composition of the 1998-99 influenza vaccine
26. The impact of influenza epidemics on hospitalizations
27. Influenza-associated morbidity and mortality in young and middle-aged women
28. The number needed to treat: A clinically useful measure of treatment effect
29. Is immunising all patients with chronic lung disease in the community against influenza cost-effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, the Netherlands
30. Relation between influenza vaccination and outpatient visits, hospitalizations, and mortality in elderly persons with chronic lung disease
31. Randomised placebo-controlled crossover trial on effects of inactivated influenza vaccine on pulmonary function in asthma
32. The safety of inactivated influenza vaccine in adults and children with asthma
33. Seroconversion after influenza vaccination in patients with lung cancer
34. Efficacy of influenza vaccination in HIV-infected persons: A randomized, double-blind, placebo-controlled trial
35. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes
36. Prevention of influenza virus infections by current inactivated influenza virus vaccines
37. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
38. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease
39. Effectiveness of pneumococcal vaccine
40. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
41. Influenza vaccination in 29 countries: An update to 1997
42. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population